CytoDyn Treats First Patient in Phase 1b/2 Clinical Trial with Leronlimab (PRO 140) for Patients with Treatment-Naïve, Metastatic Triple-Negative Breast Cancer
Stock Information for Cytodyn Inc
Loading
Please wait while we load your information from QuoteMedia.